NO20030658L - Fremgangsmåte for modulering av multippel ''lineage'' kinaseproteiner og undersökelse av forbindelser som modulerer multippel "lineage"kinaseproteiner - Google Patents
Fremgangsmåte for modulering av multippel ''lineage'' kinaseproteiner og undersökelse av forbindelser som modulerer multippel "lineage"kinaseproteinerInfo
- Publication number
- NO20030658L NO20030658L NO20030658A NO20030658A NO20030658L NO 20030658 L NO20030658 L NO 20030658L NO 20030658 A NO20030658 A NO 20030658A NO 20030658 A NO20030658 A NO 20030658A NO 20030658 L NO20030658 L NO 20030658L
- Authority
- NO
- Norway
- Prior art keywords
- kinase proteins
- lineage kinase
- multiple lineage
- investigation
- modeling
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
- C12Q1/485—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Cell Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63705400A | 2000-08-11 | 2000-08-11 | |
PCT/US2001/024822 WO2002014536A2 (en) | 2000-08-11 | 2001-08-08 | Odulating multiple lineage kinase proteins |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20030658D0 NO20030658D0 (no) | 2003-02-10 |
NO20030658L true NO20030658L (no) | 2003-04-09 |
Family
ID=24554347
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20030658A NO20030658L (no) | 2000-08-11 | 2003-02-10 | Fremgangsmåte for modulering av multippel ''lineage'' kinaseproteiner og undersökelse av forbindelser som modulerer multippel "lineage"kinaseproteiner |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP1309721A2 (no) |
JP (1) | JP2005503102A (no) |
CN (1) | CN1458979A (no) |
AU (2) | AU8317901A (no) |
BG (1) | BG107623A (no) |
BR (1) | BR0113266A (no) |
CA (1) | CA2419985A1 (no) |
CZ (1) | CZ2003680A3 (no) |
HR (1) | HRP20030162A2 (no) |
HU (1) | HUP0501110A3 (no) |
IL (1) | IL154311A0 (no) |
IS (1) | IS6711A (no) |
MX (1) | MXPA03001218A (no) |
NO (1) | NO20030658L (no) |
NZ (1) | NZ524034A (no) |
PL (1) | PL366248A1 (no) |
SK (1) | SK2692003A3 (no) |
WO (1) | WO2002014536A2 (no) |
ZA (1) | ZA200301109B (no) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6811992B1 (en) | 1998-05-14 | 2004-11-02 | Ya Fang Liu | Method for identifying MLK inhibitors for the treatment of neurological conditions |
US20060014165A1 (en) * | 2003-07-14 | 2006-01-19 | Decode Genetics Ehf. | Methods of diagnosis and treatment for asthma and other respiratory diseases based on haplotype association |
WO2005007144A2 (en) * | 2003-07-14 | 2005-01-27 | Decode Genetics Ehf | Method of diagnosis and treatment for asthma based on haplotype association |
US20060058250A1 (en) * | 2004-09-10 | 2006-03-16 | Cephalon, Inc. | Methods of treating proliferative skin diseases using carbazole derivatives |
US20160082015A1 (en) * | 2013-04-18 | 2016-03-24 | President And Fellows Of Harvard College | Methods, compositions and kits for promoting motor neuron survival and treating and diagnosing neurodegenerative disorders |
CN109073634B (zh) * | 2016-11-25 | 2022-07-08 | 基诺富公司 | 用于诱导神经干细胞的分化和保护的组合物及使用该组合物诱导神经再生的方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5756494A (en) * | 1992-07-24 | 1998-05-26 | Cephalon, Inc. | Protein kinase inhibitors for treatment of neurological disorders |
US5705511A (en) * | 1994-10-14 | 1998-01-06 | Cephalon, Inc. | Fused pyrrolocarbazoles |
US6811992B1 (en) * | 1998-05-14 | 2004-11-02 | Ya Fang Liu | Method for identifying MLK inhibitors for the treatment of neurological conditions |
TR200400635T2 (tr) * | 1998-08-26 | 2005-10-21 | Cephalon, Inc. | Çok nesilli kinaz proteinlerin modüle edilmesi |
US6841567B1 (en) * | 1999-02-12 | 2005-01-11 | Cephalon, Inc. | Cyclic substituted fused pyrrolocarbazoles and isoindolones |
-
2001
- 2001-08-08 BR BR0113266-0A patent/BR0113266A/pt not_active IP Right Cessation
- 2001-08-08 CA CA002419985A patent/CA2419985A1/en not_active Abandoned
- 2001-08-08 SK SK269-2003A patent/SK2692003A3/sk not_active Application Discontinuation
- 2001-08-08 AU AU8317901A patent/AU8317901A/xx active Pending
- 2001-08-08 JP JP2002519661A patent/JP2005503102A/ja active Pending
- 2001-08-08 NZ NZ524034A patent/NZ524034A/en unknown
- 2001-08-08 AU AU2001283179A patent/AU2001283179B2/en not_active Ceased
- 2001-08-08 HU HU0501110A patent/HUP0501110A3/hu unknown
- 2001-08-08 WO PCT/US2001/024822 patent/WO2002014536A2/en active Application Filing
- 2001-08-08 MX MXPA03001218A patent/MXPA03001218A/es not_active Application Discontinuation
- 2001-08-08 CN CN01814001A patent/CN1458979A/zh active Pending
- 2001-08-08 PL PL01366248A patent/PL366248A1/xx not_active Application Discontinuation
- 2001-08-08 EP EP01961958A patent/EP1309721A2/en not_active Withdrawn
- 2001-08-08 IL IL15431101A patent/IL154311A0/xx unknown
- 2001-08-08 CZ CZ2003680A patent/CZ2003680A3/cs unknown
-
2003
- 2003-02-10 IS IS6711A patent/IS6711A/is unknown
- 2003-02-10 ZA ZA200301109A patent/ZA200301109B/en unknown
- 2003-02-10 NO NO20030658A patent/NO20030658L/no not_active Application Discontinuation
- 2003-03-06 HR HR20030162A patent/HRP20030162A2/hr not_active Application Discontinuation
- 2003-03-10 BG BG107623A patent/BG107623A/bg unknown
Also Published As
Publication number | Publication date |
---|---|
PL366248A1 (en) | 2005-01-24 |
BR0113266A (pt) | 2005-01-04 |
AU8317901A (en) | 2002-02-25 |
NO20030658D0 (no) | 2003-02-10 |
AU2001283179B2 (en) | 2006-07-13 |
CN1458979A (zh) | 2003-11-26 |
EP1309721A2 (en) | 2003-05-14 |
SK2692003A3 (en) | 2003-08-05 |
BG107623A (bg) | 2003-11-28 |
HRP20030162A2 (en) | 2005-12-31 |
WO2002014536A2 (en) | 2002-02-21 |
HUP0501110A3 (en) | 2006-06-28 |
JP2005503102A (ja) | 2005-02-03 |
MXPA03001218A (es) | 2003-05-27 |
CA2419985A1 (en) | 2002-02-21 |
HUP0501110A2 (en) | 2006-03-28 |
IS6711A (is) | 2003-02-10 |
NZ524034A (en) | 2006-11-30 |
IL154311A0 (en) | 2003-09-17 |
ZA200301109B (en) | 2004-07-20 |
WO2002014536A9 (en) | 2003-12-18 |
WO2002014536A3 (en) | 2003-01-30 |
CZ2003680A3 (cs) | 2003-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS2142B (is) | Nýtt form S-ómeprasóls | |
NO974572D0 (no) | Cyklodextrin-forbindelser, fremgangsmåter for fremstilling og anvendelse derav | |
DE69627179T2 (de) | Substituierte 2-anilino-pyrimidines verwendbar als protein kinase inhibitoren | |
ATE172199T1 (de) | Proteinkinase-c-inhibitor | |
ID25792A (id) | Antibodi-antibodi terhadap cd40 manusia | |
DE60121953D1 (de) | Herstellungsverfahren von arzneizubereitungen | |
DE69942264D1 (de) | Hülse zum Einsetzen von chirurgischen Instrumenten | |
NO20020635L (no) | Hemmere av proteinpolymeriserings og metodene som brukes | |
NO20031152D0 (no) | Befruktningshindrende fremgangsmåte og administrasjonsform for det samme | |
NO20033387L (no) | Modifiserte antistoffer og fremgangsmåter for anvendelse | |
NO974453D0 (no) | Proteinkinase C-hemmere | |
NO20032726L (no) | Kinazolinderivater, medikamenter inneholdende disse forbindelser, deres anvendelse og fremgangsmåte for fremstilling derav | |
NO995695D0 (no) | Substituerte pyrazoler som p38-kinase-inhibitorer | |
IS6197A (is) | Aðferð og búnaður til að koma lyfjablöndum á úðaform | |
NO20015797D0 (no) | Indazolforbindelser og farmasöytiske forbindelser for inhibering av proteinkinaser, og fremgangsmåter til anvendelsederav | |
NO20002281D0 (no) | FremgangsmÕte for generering av seismiske attributter | |
NO993522D0 (no) | 4-(3-heterocyclyl-1-benzoyl)pyrazoler og anvendelse derav som herbisider | |
ATE253361T1 (de) | Mittel zur gesteuerten freisetzung von paroxetin | |
DE60210816D1 (de) | Verfahren zur herstellung von 1-(carboxymethyl)-und 1(aminocarbonyl)-pyrimidin-4-on derivaten | |
NO20012014D0 (no) | Blandinger av og fremgangsmåter for fremstilling av isotretinoin som har liten partikkelstörrelse | |
NO20003070D0 (no) | Substituert tiazolidinderivat, fremgangsmÕte for fremstilling og anvendelse derav | |
NO20012963D0 (no) | Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler | |
ATE355062T1 (de) | Retard-zubereitungen von chinolon-antibiotika und verfahren zu ihrer herstellung | |
EE04154B1 (et) | Omeprasooli valmistamise meetod | |
NO20033506D0 (no) | Parasittdrepende preparater og fremgangsmåter for anvendelse |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |